Evidence map›Paper›PMID 19659756›Full record

ReviewClinical genetics2009

Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications.

H T Lynch, P M Lynch, S J Lanspa, C L Snyder, J F Lynch, C R Boland

Registry-linked trialAbstract readHistorical ArticleReview
In one paragraph

Review in Clinical genetics, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05704010 (Role of Videocapsule Endoscopy in Lynch Syndrome), which is not on this map. Cited by 362 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
362citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05704010 narecruitingnot on this mapstarted 2018, after this paper: background citation

Role of Videocapsule Endoscopy in Lynch Syndrome: a Multicenter Italian Registry Study

TypeinterventionalSponsorSan Raffaele UniversityRan2018 to 2029Enrolled100ConditionsLynch Syndrome, Lynch Syndrome I, Lynch Syndrome II, MLH1 Gene MutationArmsVideo capsule endoscopy
3 · Its place in the literature

Who cites it

362 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Outcomes of 'in-house' genetic testing within a specialist hereditary colorectal cancer registry.Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland · 2026
    Article
  9. Article
  10. Deciphering survival disparities in endometrial cancer: a focus on mismatch repair pathway integrity (systematic review and meta-analysis).Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

302 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

H T LynchDepartment of Preventive Medicine, Creighton University School of Medicine, Omaha, NE 68178, USA. htlynch@creighton.edu
P M Lynch
S J Lanspa
C L Snyder
J F Lynch
C R Boland

Funding

The Biology and Diagnosis of HNPCCR01CA072851 · NCI · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI GOEL, AJAY · 1996 to 2019
$6.6M
EDRN--THE HEREDITARY CANCER CLINICAL CENTERU01CA086389 · NCI · CREIGHTON UNIVERSITY · PI LYNCH, HENRY T · 2000 to 2010
$6.2M
NCI NIH HHS 1U01 CA 86389NCI NIH HHS CA72851NCI NIH HHS R01 CA072851NCI NIH HHS U01 CA086389
6 · The paper itself

Abstract

More than one million patients will manifest colorectal cancer (CRC) this year of which, conservatively, approximately 3% (approximately 30,700 cases) will have Lynch syndrome (LS), the most common hereditary CRC predisposing syndrome. Each case belongs to a family with clinical needs that require genetic counseling, DNA testing for mismatch repair genes (most frequently MLH1 or MSH2) and screening for CRC. Colonoscopy is mandated, given CRC's proximal occurrence (70-80% proximal to the splenic flexure). Due to its early age of onset (average 45 years of age), colonoscopy needs to start by age 25, and because of its accelerated carcinogenesis, it should be repeated every 1 to 2 years through age 40 and then annually thereafter. Should CRC occur, subtotal colectomy may be necessary, given the marked frequency of synchronous and metachronous CRC. Because 40-60% of female patients will manifest endometrial cancer, tailored management is essential. Additional extracolonic cancers include ovary, stomach, small bowel, pancreas, hepatobiliary tract, upper uroepithelial tract, brain (Turcot variant) and sebaceous adenomas/carcinomas (Muir-Torre variant). LS explains only 10-25% of familial CRC.

Indexed as

Mass ScreeningColorectal Neoplasms, Hereditary NonpolyposisGenetic CounselingGenetic PrivacyHistory, 19th CenturyHistory, 20th CenturyHumansInformed Consent

Identifiers

PMID19659756
PMCPMC2846640

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.